83
Views
18
CrossRef citations to date
0
Altmetric
Review

Emerging treatments for irritable bowel syndrome

&
Pages 9-21 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

John McLaughlin & Lesley A Houghton. (2006) The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. Expert Opinion on Drug Safety 5:2, pages 313-327.
Read now

Articles from other publishers (17)

Zara Manuelyan, Keila Siomara Muñiz & Ellen Stein. (2020) Common Urinary and Bowel Disorders in the Geriatric Population. Medical Clinics of North America 104:5, pages 827-842.
Crossref
Jeanette Sørensen, Birgitte Schantz Laursen, Asbjørn Mohr Drewes & Anne Lund Krarup. (2019) The Incidence of Sexual Dysfunction in Patients With Irritable Bowel Syndrome. Sexual Medicine 7:4, pages 371-383.
Crossref
Ulrich Desselberger. (2017) 7th European rotavirus biology conference, Cork/Ireland, 18–21 June 2017. Virus Research 240, pages 197-199.
Crossref
Ji Eun Kim, Eun Kyoung Koh, Sung Hwa Song, Ji Eun Sung, Hyun Ah Lee, Hong Gu Lee, Young Whan Choi & Dae Youn Hwang. (2017) Effects of five candidate laxatives derived from Liriope platyphylla on the 5-HT receptor signaling pathway in three cell types present in the transverse colon. Molecular Medicine Reports 15:1, pages 431-441.
Crossref
Kamesh Gupta, Harparam Singh Ghuman & Shivani Vijay Handa. (2017) Review of Rifaximin: Latest Treatment Frontier for Irritable Bowel Syndrome Mechanism of Action and Clinical Profile. Clinical Medicine Insights: Gastroenterology 10, pages 117955221772890.
Crossref
Megan Friedrich, Sarah E. Grady & Geoffrey C. Wall. (2010) Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression. Clinical Therapeutics 32:7, pages 1221-1233.
Crossref
Elizabeth L. Gallantine & Theo F. Meert. (2008) Antinociceptive and Adverse Effects of µ- and κ-Opioid Receptor Agonists: A Comparison of Morphine and U50488-H. Basic & Clinical Pharmacology & Toxicology 103:5, pages 419-427.
Crossref
s. c. duncker, l. wang, p. hols & j. bienenstock. (2008) The d-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model. Neurogastroenterology & Motility 20:7, pages 843-850.
Crossref
Kareem Harish, Kizhekkan Hazeena, Varghese Thomas, Sunil Kumar, Tony Jose & Puthiyaveetil Narayanan. (2007) Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome. Journal of Gastroenterology and Hepatology 22:8, pages 1183-1189.
Crossref
A L D'Souza. (2007) Ageing and the gut. Postgraduate Medical Journal 83:975, pages 44-53.
Crossref
G.A. Hicks. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 643 670 .
Eli D. Ehrenpreis. 2006. Constipation. Constipation 49 56 .
B. D. CASH & W. D. CHEY. (2005) Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation. Alimentary Pharmacology and Therapeutics 22:11-12, pages 1047-1060.
Crossref
Danial E. Baker. (2005) Rationale for using serotonergic agents to treat irritable bowel syndrome. American Journal of Health-System Pharmacy 62:7, pages 700-711.
Crossref
Leslie A Aaron & Dedra Buchwald. (2003) Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Practice & Research Clinical Rheumatology 17:4, pages 563-574.
Crossref
Mark Berner Hansen. (2003) The Enteric Nervous System III: A Target for Pharmacological Treatment. Pharmacology & Toxicology 93:1, pages 1-13.
Crossref
Hui-Bin Qi. (2003) Effect of enterokinetic prucalopride on intestinal motility in fast rats. World Journal of Gastroenterology 9:9, pages 2065.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.